Evidence map›Paper›PMID 26866054›Full record

ArticleCellular and molecular gastroenterology and hepatology2016

Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon.

David Bernardo, Lydia Durant, Elizabeth R Mann, Elizabeth Bassity, Enrique Montalvillo, Ripple Man, Rakesh Vora, Durga Reddi, Fahri Bayiroglu, Luis Fernández-Salazar and 20 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Type 1 and CD103European journal of immunology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Identification of CX3CR1iScience · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Two distinct colonic CD14Mucosal immunology · 2019
    Article
  18. Human intestinal pro-inflammatory CD11cMucosal immunology · 2018
    Article
  19. To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.Journal of neuropathology and experimental neurology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 12 institutions in 4 countries.

David BernardoAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Lydia DurantAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Elizabeth R MannAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Elizabeth BassityGut Health and Food Safety Programme, Institute of Food Research, Norwich, United Kingdom.
Enrique MontalvilloMucosal Immunology Group, Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain.
Ripple ManSt. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Rakesh VoraAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Durga ReddiAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Fahri BayirogluDepartment of Physiology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey; Faculty of Farmacy, Agri İbrahim Cecen University, Agri, Turkey.
Luis Fernández-SalazarGastroenterology Service, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Nick R EnglishAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Simon T C PeakeAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Jon LandyAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Gui H LeeAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
George MalietzisAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Yi Harn SiawAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Aravinth U MurugananthanAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Phil HendyAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom; St. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Eva Sánchez-RecioAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Robin K S PhillipsSt. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Jose A GarroteMucosal Immunology Group, Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid-CSIC, Valladolid, Spain; Genetics and Molecular Biology Department, Clinical Laboratory Service, Hospital Universitario Rio Hortega, Valladolid, Spain.
Paul ScottPathogen Genomics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
Julian ParkhillPathogen Genomics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
Malte PaulsenNational Heart and Lung Institute, Imperial College London, London.
Ailsa L HartSt. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Hafid O Al-HassiAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Eduardo ArranzSt. Mark's Hospital, North West London Hospitals NHS Trust, Harrow, United Kingdom.
Alan W WalkerPathogen Genomics Group, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, United Kingdom; Microbiology Group, Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, United Kingdom.
Simon R CardingGut Health and Food Safety Programme, Institute of Food Research, Norwich, United Kingdom; Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
Stella C KnightAntigen Presentation Research Group, Imperial College London, Harrow, United Kingdom.
Imperial College London · GBLondon North West Healthcare NHS Trust · GBSt Mark's Hospital · GBWellcome Sanger Institute · GBAnkara Yıldırım Beyazıt University · TRHospital Clínico Universitario de Valladolid · ESInstituto de Biomedicina y Genética Molecular de Valladolid · ESQuadram Institute · GBUniversidad de Valladolid · ESUniversity of Aberdeen · GBUniversity of East Anglia · GBUniversity of Glasgow · GB

Funding

BASIC SCIENCE RESEARCH IN DIGESTIVE DISEASEST32DK007632 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 1989 to 2018
$5.4M
NIDDK NIH HHS T32 DK007632Wellcome TrustWorldwide Cancer Research 12-0234
6 · The paper itself

Abstract

BACKGROUND &

aimsMost knowledge about gastrointestinal (GI)-tract dendritic cells (DC) relies on murine studies where CD103

methodsPaired proximal (right/ascending) and distal (left/descending) human colonic biopsies from 95 healthy subjects were taken; DC were assessed by flow cytometry and microbiota composition assessed by 16S rRNA gene sequencing.

resultsColonic DC identified were myeloid (mDC, CD11c

conclusionsProximal colonic DC subsets differ from those in distal colon and are more mature. Targeted immunotherapy using DC in T-cell mediated GI tract inflammation may therefore need to reflect this immune compartmentalization.

Indexed as

AMOVA, analysis of molecular varianceCCL, chemokine (C-C motif) ligandCCR2CCR, chemokine (C-C motif) receptorCFSE, 5-carboxy fluorescein diacetate succinimidyl esterDC, dendritic cellsDendritic CellsDistal ColonDL, detection limitFACS, fluorescence-activated cell sortingFITC, fluorescein isothiocyanateGI, gastrointestinalHuman Gastrointestinal TractIL, interleukinILT3, Ig-like transcript 3LPMC, lamina propria mononuclear cellsmDC, myeloid dendritic cellMicrobiotaMφ, macrophagesPBMC, peripheral blood mononuclear cellsPCR, polymerase chain reactionpDC, plasmacytoid dendritic cellProximal ColonRALDH2, retinaldehyde dehydrogenase type 2SIRPα, signal regulatory protein αSPB, sodium phosphate bufferTreg, regulatory T-cells

Identifiers

PMID26866054
PMCPMC4705905
OpenAlexW1458827961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.